MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from redemption of inve...
Increase in accounts payable and...
Stock based compensation
Others
Negative Cash Flow Breakdown
Net loss
Purchase of investments
Payment of amounts due to office...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,371,042
-4,997,735
-4,348,373
-3,948,165
Stock based compensation
532,951
444,525
283,205
182,188
Amortization of intangibles
25,000
25,000
25,000
25,000
Realized and unrealized gain and accrued interest on investments
53,491
110,527
77,044
-2,185
Increase in accounts payable and accrued expenses
1,267,132
-200,904
-258,491
1,427,052
Decrease in prepaid expenses and other assets
-455,110
29,282
659,322
-86,281
Net cash used in operating activities
-3,144,340
-4,868,923
-5,035,025
-2,225,459
Purchase of investments
982,207
980,685
12,264,069
-
Proceeds from redemption of investments
5,000,000
5,099,599
995,720
2,537,873
Net cash provided by investing activities
4,017,793
4,118,914
-11,268,349
2,537,873
Payment of amounts due to officers
150,000
150,000
150,000
150,000
Proceeds from sale of equity securities, net
-
-
18,441,177
172,958
Proceeds from exercise of warrants, net
-1,947
205,982
-
-
Net cash used in financing activities
-151,947
55,982
18,291,177
-150,000
Effect of foreign exchange rate on changes on cash
-423
454
-613
-
Net change in cash and cash equivalents
721,083
-693,573
1,987,190
-1,792,437
Cash and cash equivalents - beginning of period
3,124,523
3,818,096
1,830,906
3,623,343
Cash and cash equivalents - end of period
3,845,606
3,124,523
3,818,096
1,830,906
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from redemption
of investments
$5,000,000
(12.29%↑ Y/Y)
Net cash provided by
investing activities
$4,017,793
(-9.77%↓ Y/Y)
Canceled cashflow
$982,207
Net change in cash
and cash...
$721,083
(136.89%↑ Y/Y)
Canceled cashflow
$3,296,710
Purchase of investments
$982,207
Increase in accounts
payable and accrued...
$1,267,132
(709.32%↑ Y/Y)
Stock based
compensation
$532,951
(-21.84%↓ Y/Y)
Decrease in prepaid
expenses and other assets
-$455,110
(5.22%↑ Y/Y)
Amortization of intangibles
$25,000
(-50.00%↓ Y/Y)
Net cash used in
operating activities
-$3,144,340
(49.93%↑ Y/Y)
Net cash used in
financing activities
-$151,947
(-19.60%↓ Y/Y)
Effect of foreign
exchange rate on changes...
-$423
Canceled cashflow
$2,280,193
Net loss
-$5,371,042
(28.46%↑ Y/Y)
Payment of amounts due to
officers
$150,000
(-50.00%↓ Y/Y)
Proceeds from exercise of
warrants, net
-$1,947
Realized and unrealized
gain and accrued...
$53,491
(-62.06%↓ Y/Y)
Buy us a coffee
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)